About the client and their vision
Noctura 400, developed by PolyPhotonix, is an innovative, clinically evaluated sleep mask designed to treat and prevent diabetic retinopathy and diabetic macular oedema. Conditions that can lead to vision loss in people with diabetes. By delivering low-level light therapy during sleep, the mask reduces retinal oxygen demand, offering a non-invasive alternative to traditional treatments like injections or laser therapy. Recognized by the NHS and backed by studies showing clinical improvement in a majority of users, Noctura 400 is transforming eye care for diabetics worldwide.
Noctura 400 sought to increase public awareness of their groundbreaking technology ahead of a European launch. They tasked us with producing engaging video content to showcase real patient experiences, explain the science behind the mask, and reach diverse audiences across multiple platforms. Our services included:
